Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

ConditionsStatin Cardiovascular Risk Factors Primary Prevention Adherence, Medication

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40-69

SponsorZhang longjiang,MD

About this trial

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.

Eligibility criteria

Qualifiers

Nanjing residents who have no plans to leave in the next 5 years

Aged from 40 to 69 years

Free of any known clinically cardiovascular disease Able to comprehend and sign an informed consent form

Disqualifiers

Serious liver dysfunction, defined as AST or ALT > 3 times the normal upper limit

Chronic kidney disease (CKD) > stage 4, defined as eGFR < 30 ml/min/1.73 m2

Prior CCTA or invasive coronary angiography within the last 5 years

Any contraindications for CCTA

Trial design

Treatments tested in this trial

Coronary Computed Tomography Angiography
Traditional cardiovascular risk stratification

Treatment groups

3,400 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Zhang longjiang,MD

Lead sponsor

Jinling Hospital, China

Sponsor institution

Source ClinicalTrials.gov